The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
J | Antiinfectives for systemic use | |
2
|
J07 | Vaccines | |
3
|
J07B | Viral vaccines | |
4
|
J07BX | Other viral vaccines | |
5
|
J07BX05 |
| Active Ingredient |
|---|
|
Respiratory syncytial virus vaccine is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by Respiratory Syncytial Virus. There are three types of RSV vaccine. The first one is a bivalent, recombinant vaccine, containing two recombinant stabilised RSV prefusion F antigens representing subgroups RSV-A and RSV-B. The second one is a RSVPreF3 vaccine which combines the RSV-specific antigen with an adjuvant system (AS01E), designed to enhance antigen-specific cellular immune response and neutralizing antibodies response in individuals with pre-existing immunity against RSV, and an mRNA-based vaccine that stimulates production of RSV-A and RSV-B neutralising antibodies and induction of antigen-specific cellular immune responses. |
| Document | Type | Information Source | |
|---|---|---|---|
| ABRYSVO Powder and solvent for solution for injection | MPI, EU: SmPC | European Medicines Agency (EU) | |
| AREXVY Powder for suspension for injection | MPI, EU: SmPC | European Medicines Agency (EU) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.